author-photo

Hareesh B. Nair

University of Texas Health Science Center at San Antonio

71

Papers

1249

Citations

Citation Trend

Filter By

Papers (47) Sort By

Journal Conference Others

Abstract 1253: Therapeutic targeting of endometrial cancer with novel LIFR inhibitor EC359

2021
Show All
- Source
- Cite
- Save
Citations (0)
Targeting LIF/LIFR signaling in cancer

2021 Genes and Diseases
Show All
- Source
- Cite
- Save
Citations (0)
LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer.

2021 Cell death discovery
Show All
- Source
- Cite
- Save
Citations (1)
Utilizing cell line-derived organoids to evaluate the efficacy of a novel LIFR-inhibitor, EC359 in targeting pancreatic tumor stroma.

2019 Genes & Cancer
Show All
- Source
- Cite
- Save
Citations (8)
Abstract 4316: Targeting LIFR overcomes HDAC inhibitor resistance in ovarian cancer

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
EC313-a tissue selective SPRM reduces the growth and proliferation of uterine fibroids in a human uterine fibroid tissue xenograft model.

2019 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 4716: Therapeutic utility of EC359 for targeting oncogenic LIFR signaling in triple negative breast cancer

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling

2018 Oncotarget
Show All
- Source
- Cite
- Save
Citations (34)
Abstract 5792: Development of cell line derived organoids to evaluate stroma targeted therapies in pancreatic cancer

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Effects of Combination of Estradiol with Selective Progesterone Receptor Modulators (SPRMs) on Human Breast Cancer Cells In Vitro and In Vivo.

2016 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (2)